SuperworthPMGC ELAB
- Market cap
- $2.2M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.8×
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- $2.6M
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- n/m
- not a meaningful number
PMGC trades at 0.8× sales. Revenue was $2.6M over the last twelve months.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $554.7K−100% | n/a | $614.6K+330% | $605.5K+91% | $527.5K−5% | n/a | n/a | n/a | $285.9K−46% | $304.1K | $682K | $1.3M | |
| Cost of revenue | $188.5K−100% | n/a | $168.9K+280% | $166.3K+54% | $133.6K−29% | n/a | n/a | n/a | $207.9K+56% | $196.9K | $451.5K | $920.9K |
| Gross profit | $366.1K−100% | n/a | $445.7K+353% | $439.3K+111% | $393.9K+8% | n/a | n/a | n/a | $78K−80% | $107.3K | $230.5K | $385.7K |
| R&D | $86.4K−100% | n/a | $2.8K−97% | $34.8K−74% | $4.1K−95% | $45K | $32.4K+1066% | $66.7K+92% | $15K+266% | $32.9K−27% | $47.1K+45% | $310.2K+365% |
| SG&A | $764.6K−100% | n/a | $264K−51% | $281.9K−56% | $178.3K−77% | $660.9K | $244.6K−7% | $402.2K+43% | $791K+344% | $1M+52% | $1.4M+479% | $1.6M+306% |
| −$785.6K | n/a | −$1.7M+99% | −$1.4M+34% | −$625.6K−20% | −$1.3M | n/a | n/a | −$2.2M+252% | −$2.9M+123% | n/a | n/a | |
| Interest expense | $5.7K−99% | n/a | $19.2K+627% | $23.6K+435% | $641.8K+11134% | $50.6K | $10.5K−45% | $2−100% | $17.4K−97% | $229.8K+354% | $474.2K+4427% | $582.2K+29111950% |
| Net income | −$783K−100% | −$1.2M | −$1.4M+29% | −$1.4M+10% | −$1.5M+92% | −$1.9M+67% | −$1.6M+15% | −$562.4K−60% | −$2.6M+73% | −$3M+54% | −$5M+209% | −$2.9M+423% |
| −$91728000.00 | −$100.80 | −$36907.08 | −$35534.52 | −$63786.96−100% | n/a | −$2437.64−93% | −$391.38−99% | −$1188.00−98% | n/a | −$112.19−95% | −$6.07−98% | |
| 0 | 11.3K | 15 | 16 | 19+220970% | n/a | 649+4299% | 1.5K+9416% | 2.2K+11587% | n/a | 44.5K+6754% | 487.6K+32836% |
Operating income: Q4 FY24 and Q4 FY25: not printed by the filing, worked out from its own lines.
Interest expense: Q1 FY23: 6 months less the 3 months printed beside them.
EPS, diluted: Q4 FY23: quarter's net income to common over its shares, to the cent.
Diluted shares: 10 periods, Q3 FY23 to Q2 FY26: not printed by the filing, worked out from its own lines.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest PMGC's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ELABPMGC | $2.2M | n/m | n/a | 0.8× | n/m | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $7.7M | 47.5× | 9.6× | 2.8× | +40% | 4.7% | |
| EDUCEducational Development | $8.7M | 5.4× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $13.6M | 6.1× | 13.6× | 0.1× | −6% | 1.7% | |
| MDRRMedalist Diversified | $15.4M | 2.5× | 3.0× | 1.6× | −1% | 80.2% | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| MXCMexco Energy | $20.5M | 13.4× | 13.3× | 3.0× | −9% | 23.3% | |
| CKXCKX Lands | $21.5M | 7.4× | 32.6× | 31.0× | −17% | n/m | |
| Peer median | $16.8M | 7.0× | 13.4× | 1.0× | −7% | 4.7% |
More on PMGC
Each number over time
Its groups
About
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .